These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Serum cholinesterase isoenzyme studies in diseases of the liver, biliary tract and pancreas]. Kiss S, Szécsey G, Szabó J. Orv Hetil; 1975 Dec 14; 116(50):2936-8. PubMed ID: 1196633 [No Abstract] [Full Text] [Related]
8. Aldolase isoenzymes in liver cirrhosis and primary liver cell cancer. Lehmann FG, Kornacher J. Digestion; 1975 Dec 14; 12(2):118-22. PubMed ID: 169180 [Abstract] [Full Text] [Related]
12. Increase of fucosylated serum cholinesterase in relation to high risk groups for hepatocellular carcinomas. Ohkura T, Hada T, Higashino K, Ohue T, Kochibe N, Koide N, Yamashita K. Cancer Res; 1994 Jan 01; 54(1):55-61. PubMed ID: 8261462 [Abstract] [Full Text] [Related]
13. [Serum arginase activity in patients with liver cirrhosis and hepatocellular carcinoma]. Chrzanowska A, Mielczarek-Puta M, Skwarek A, Krawczyk M, Barańczyk-Kuźma A. Wiad Lek; 2007 Jan 01; 60(5-6):215-8. PubMed ID: 17966882 [Abstract] [Full Text] [Related]